Citation: Twr. Hansen, Guidelines for treatment of neonatal jaundice. Is there a place fur evidence-based medicine?, ACT PAEDIAT, 90(3), 2001, pp. 239-241
Citation: Twr. Hansen et al., Subcellular localization of bilirubin in rat brain after in vivo i.v. administration of [H-3]bilirubin, PEDIAT RES, 49(2), 2001, pp. 203-207
Authors:
Hogasen, AKM
Overlie, I
Hansen, TWR
Abrahamsen, TG
Finne, PH
Hogasen, K
Citation: Akm. Hogasen et al., The analysis of the complement activation product SC5b-9 is applicable in neonates in spite of their profound C9 deficiency (vol 28, pg 39, 2000), J PERIN MED, 28(3), 2000, pp. NIL_4-NIL_4
Authors:
Hogasen, AKM
Overlie, I
Hansen, TWR
Abrahamsen, TG
Finne, PH
Hogasen, K
Citation: Akm. Hogasen et al., The analysis of the complement activation product SC5 b-9 is applicable inneonates in spite of their profound C9 deficiency, J PERIN MED, 28(1), 2000, pp. 39-48
Citation: Twr. Hansen et Jw. Allen, Bilirubin oxidation by brain mitochondrial membranes is not affected by hyperosmolality, BIOL NEONAT, 78(1), 2000, pp. 68-69
Citation: Twr. Hansen et al., Oxidation of bilirubin in the brain - Further characterization of a potentially protective mechanism, MOL GEN MET, 68(3), 1999, pp. 404-409